Toxic microbiome and progression of chronic kidney disease: insights from a longitudinal CKD-microbiome study
-
By
-
May 1, 2026
Objective:
To clarify the relationships among gut microbiome composition, diet, and the progression of chronic kidney disease (CKD), highlighting the significance of these relationships for potential therapeutic interventions.
Key Findings:
- CKD alters gut microbiome composition, increasing uraemic toxin precursor species, which may lead to further health complications.
- Plasma levels of uraemic toxins correlate strongly with microbiome composition, indicating a direct link between gut health and CKD progression.
- Faecal microbiota transplantation in mice led to increased serum uraemic toxins and kidney fibrosis, suggesting a causal relationship.
- Gut microbiome-derived metabolites are associated with rapid kidney function decline, independent of traditional risk factors, emphasizing the need for microbiome-focused interventions.
Interpretation:
Dysbiosis in CKD contributes to the accumulation of uraemic toxins, which may exacerbate CKD progression through various mechanisms, including inflammation and the production of harmful metabolites, warranting further investigation into these pathways.
Limitations:
- The definition of 'fast progressors' may introduce bias affecting patients with lower baseline GFR; future studies should consider alternative definitions.
- The study did not assess local inflammation histologically in progressing CKD patients, which could provide valuable insights into the inflammatory processes involved.
Conclusion:
The study enhances understanding of the gut-kidney axis in CKD, highlighting the potential of dietary interventions to mitigate dysbiosis effects, while further research is urgently needed to identify primary uraemic toxins and their mechanisms.
